Login to Your Account



Clinical Failures Mark End for Agennix, Phytopharm

By Nuala Moran
Staff Writer

Wednesday, May 29, 2013
LONDON – Two of Europe's longest-standing public biotechs are leaving the stage following clinical trial failures, with Agennix AG going into liquidation and Phytopharm plc announcing a reverse merger.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription